- Early stage VC,
- Later stage VC,
- Other
Biovest International, Inc. is a publicly-traded (OTCQB: BVTI), emerging leader in the field of active personalized immunotherapy targeting life-threatening cancers of the blood system, and markets state-of-the-art hollow fiber bio-production instruments, as well as provides custom cell culture services, including contract manufacturing.
- CompanyAmountRound
- Example example company Inc$ 1,000,000Investor meetings
- Company & Company€ 11,000,000Series C funding
- Example$ 524,000Seed round A
Email visible after logging in
Example Exampleexample
Biotechnology